The American Cancer Society has changed its prostate cancer screening recommendations. The change follows two studies highlighting the limits of the prostate-specific antigen or PSA blood test and digital rectal exam. The ACS says doctors now should emphasize the limits and risks as well as benefits of prostate screening to patients before doing the tests. These new guidelines have some confused.
Updated 5:35 PM